ストックスクリーナーアプリを入手
34.83
0.52%
0.18
アフターアワーズ：
35.02
0.19
+0.55%
Exelixis Inc (EXEL) 最新ニュース
3 Reasons Growth Investors Will Love Exelixis (EXEL) - Yahoo Finance
Ontario Teachers Pension Plan Board Reduces Position in Exelixis, Inc. (NASDAQ:EXEL) - MarketBeat
EULAV Asset Management Sells 45,000 Shares of Exelixis, Inc. (NASDAQ:EXEL) - MarketBeat
Thyroid Cancer Therapeutics Market May See a Big Move| Pfizer, Exelixis, AbbVie - openPR
Zacks.com featured highlights Amazon, Maplebear, Exelixis and Doximity - Yahoo Finance
Exelixis exec Haley Patrick sells $1.43 million in stock By Investing.com - Investing.com Australia
Exelixis exec Haley Patrick sells $1.43 million in stock - Investing.com
Janney Montgomery Scott LLC Decreases Stock Holdings in Exelixis, Inc. (NASDAQ:EXEL) - MarketBeat
Exelixis, Inc. (NASDAQ:EXEL) Shares Purchased by Seizert Capital Partners LLC - MarketBeat
1 No-Brainer Stock to Buy With $40 - AOL
Cornercap Investment Counsel Inc. Reduces Stake in Exelixis, Inc. (NASDAQ:EXEL) - MarketBeat
18,300 Shares in Exelixis, Inc. (NASDAQ:EXEL) Bought by Entropy Technologies LP - MarketBeat
Exelixis, Inc. (NASDAQ:EXEL) Receives $31.44 Consensus Target Price from Analysts - MarketBeat
Principal Financial Group Inc. Reduces Position in Exelixis, Inc. (NASDAQ:EXEL) - MarketBeat
Here's Why Exelixis (EXEL) is a Strong Momentum Stock - MSN
CWA Asset Management Group LLC Invests $577,000 in Exelixis, Inc. (NASDAQ:EXEL) - MarketBeat
Here's Why Exelixis (EXEL) is a Strong Value Stock - MSN
What Makes Exelixis (EXEL) a Strong Momentum Stock: Buy Now? - MSN
Here is Why Growth Investors Should Buy Exelixis (EXEL) Now - MSN
Los Angeles Capital Management LLC Has $46.47 Million Stock Position in Exelixis, Inc. (NASDAQ:EXEL) - MarketBeat
Van ECK Associates Corp Boosts Position in Exelixis, Inc. (NASDAQ:EXEL) - MarketBeat
Have Insiders Sold Exelixis Shares Recently? - Simply Wall St
Exelixis CSO Aftab Dana sells $3.39 million in stock - Investing.com
Exelixis to Webcast Fireside Chats as Part of Investor Conferences in November - BioSpace
Exelixis CSO Aftab Dana sells $3.39 million in stock By Investing.com - Investing.com UK
Exelixis to shed 212K sf of industrial in Alameda - The Real Deal
Robeco Institutional Asset Management B.V. Purchases 350,026 Shares of Exelixis, Inc. (NASDAQ:EXEL) - MarketBeat
Exelixis stock soars to 52-week high, reaches $35.76 - Investing.com
Exelixis's SWOT analysis: oncology leader's stock poised for growth By Investing.com - Investing.com Australia
Exelixis EVP sells $1.7 million in stock - Investing.com India
Exelixis EVP sells $1.7 million in stock By Investing.com - Investing.com Canada
Exelixis director George Poste sells $1.02 million in shares - Investing.com India
Exelixis director George Poste sells $1.02 million in shares By Investing.com - Investing.com Canada
Earnings Estimates Rising for Exelixis (EXEL): Will It Gain? - MSN
Exelixis (NASDAQ:EXEL) Sets New 52-Week HighTime to Buy? - MarketBeat
Exelixis, Inc. (NASDAQ:EXEL) Shares Bought by Capital Management Corp VA - MarketBeat
Exelixis's SWOT analysis: oncology leader's stock poised for growth - Investing.com India
Exelixis Beats on Q3 Earnings and Sales, Raises Annual Outlook - MSN
Exelixis (EXEL) Reliance on International Sales: What Investors Need to Know - Yahoo Finance
3 Magnificent Stocks Under $100 to Buy in November - The Motley Fool
New York State Teachers Retirement System Purchases 20,008 Shares of Exelixis, Inc. (NASDAQ:EXEL) - MarketBeat
Dana Aftab Sells 1,162 Shares of Exelixis, Inc. (NASDAQ:EXEL) Stock - MarketBeat
Exelixis cso sells stock worth $36,486 By Investing.com - Investing.com Australia
Exelixis cso sells stock worth $36,486 - Investing.com India
Exelixis (NASDAQ:EXEL) Issues Earnings Results, Beats Estimates By $0.04 EPS - MarketBeat
Trend Tracker for (EXEL) - Stock Traders Daily
Exelixis, Inc. Just Recorded A 18% EPS Beat: Here's What Analysts Are Forecasting Next - Yahoo Finance
Exelixis price target raised to $38 from $33 at Truist - MSN
Stephens Investment Management Group LLC Has $98.78 Million Position in Exelixis, Inc. (NASDAQ:EXEL) - MarketBeat
Exelixis: Cabometyx Drives Revenue While Zanzalintinib Emerges As Future Growth Engine - Seeking Alpha
Exelixis, Inc. (NASDAQ:EXEL) Q3 2024 Earnings Call Transcript - Insider Monkey
Exelixis stock hits 52-week high at $31.3 amid robust growth - Investing.com Australia
0.93%
3.55%
大文字化:
|
ボリューム (24 時間):